Full index of posts »
GSK is down pre-market despite a positive panel recommendation. Some concerns about safety in label. Good buying opportunity? Nov 17, 2010
The latest issue of New England Journal of Medicine has a fascinating article on Pfizer's anti-NGF antibody for treatment of osteoarthritis Oct 14, 2010
Arena getting hit today after some FDA questions on its safety and efficacy. Down about 25% Sep 14, 2010
- John Tucker on So Much For Angelina Jolie's Bump Katan, the technical analysis is a good measure...
- Dopamine on Wikileaks and the US Economy I think Wikileaks deserves some time to breathe...
- Ketan Desai on Chemicals or biologics? An example in Rheumatoid Arthritis 'Morning John,We have been using modeling to de...
- John Tucker on Chemicals or biologics? An example in Rheumatoid Arthritis Hi Ketan,As a chemist, I can still understand t...
- So Much For Angelina Jolie's Bump (1 Comment)